rs142355489
Variant summary
Our verdict is Likely benign. The variant received -4 ACMG points: 0P and 4B. BP4_Strong
The NM_018326.3(GIMAP4):c.34C>G(p.Pro12Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000109 in 1,605,528 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. P12S) has been classified as Uncertain significance.
Frequency
Consequence
NM_018326.3 missense
Scores
Clinical Significance
Conservation
Publications
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GIMAP4 | NM_018326.3 | c.34C>G | p.Pro12Ala | missense_variant | Exon 2 of 3 | ENST00000255945.4 | NP_060796.1 | |
GIMAP4 | NM_001363532.2 | c.34C>G | p.Pro12Ala | missense_variant | Exon 2 of 3 | NP_001350461.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000725 AC: 11AN: 151758Hom.: 0 Cov.: 30 show subpopulations
GnomAD2 exomes AF: 0.0000518 AC: 13AN: 251046 AF XY: 0.0000737 show subpopulations
GnomAD4 exome AF: 0.000113 AC: 164AN: 1453770Hom.: 0 Cov.: 28 AF XY: 0.000102 AC XY: 74AN XY: 723692 show subpopulations
GnomAD4 genome AF: 0.0000725 AC: 11AN: 151758Hom.: 0 Cov.: 30 AF XY: 0.0000540 AC XY: 4AN XY: 74090 show subpopulations
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.34C>G (p.P12A) alteration is located in exon 2 (coding exon 1) of the GIMAP4 gene. This alteration results from a C to G substitution at nucleotide position 34, causing the proline (P) at amino acid position 12 to be replaced by an alanine (A). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at